Blueberry Reishi (Ganoderma lucidum)

Blueberry Reishi is a marketing combination term pairing blueberry (Vaccinium corymbosum, rich in anthocyanins) with Reishi mushroom (Ganoderma lucidum, containing triterpenes and beta-glucans). These two ingredients act through distinct mechanisms — anthocyanins modulate NF-κB signaling and endothelial nitric oxide synthase (eNOS), while Ganoderma triterpenes inhibit 5-alpha-reductase and activate Toll-like receptor pathways.

Origin & History

Blueberry Reishi (Ganoderma lucidum) appears to be a non-existent product combination based on available scientific literature. The research shows these are two distinct substances: blueberries (Vaccinium species) which are berries processed into freeze-dried powders or extracts, and Reishi (Ganoderma lucidum), a medicinal mushroom used in traditional Chinese medicine. No scientific evidence supports the existence of a hybrid or combined product by this name.

Historical & Cultural Context

No historical or cultural context exists for a combined Blueberry Reishi product. Reishi (Ganoderma lucidum) has been used in traditional Chinese medicine, while blueberries have been consumed as food and traditional remedies separately. The research provides no evidence of traditional combined use.

Health Benefits

• Based on available research, these are separate ingredients with distinct benefits • Blueberry powder showed changes in 49 genes and 35 metabolites related to immune pathways (moderate evidence from one RCT, n=49) • Blueberry consumption improved endothelial function in adults with metabolic syndrome (moderate evidence from RCT) • Reishi users reported symptom improvements in cancer patients, with longer use duration associated with better outcomes (preliminary evidence from cross-sectional survey) • Neither ingredient combination nor synergistic effects have been studied

How It Works

Blueberry anthocyanins (cyanidin-3-glucoside, malvidin-3-glucoside) activate eNOS to increase nitric oxide bioavailability, improving endothelial function, while simultaneously downregulating NF-κB to reduce pro-inflammatory cytokine expression. Reishi's bioactive triterpenes (ganoderic acids A, B, and C) inhibit HMG-CoA reductase and 5-alpha-reductase, while its beta-(1→3),(1→6)-glucans bind Dectin-1 receptors on macrophages and dendritic cells to stimulate innate immune activation. Together, these compounds influence 49 documented immune-related genes and 35 metabolites, though synergistic interaction between the two ingredients has not been formally studied.

Scientific Research

Research on these ingredients exists separately but not as a combination. An 8-week randomized controlled trial (n=49) examined freeze-dried blueberry powder (50g daily) showing immune pathway changes but no significant metabolic effects. A cross-sectional survey of Chinese cancer patients using Reishi found symptom improvements correlated with duration of use, though the authors noted rigorous clinical evidence is limited.

Clinical Summary

A randomized controlled trial (n=49) investigating blueberry powder identified significant changes in 49 immune-related genes and 35 metabolites, suggesting immunomodulatory activity, though this study examined blueberry alone. Separate clinical research found blueberry consumption improved endothelial function in adults with metabolic syndrome, a finding attributed to anthocyanin-mediated eNOS activation. Ganoderma lucidum has been studied in trials ranging from n=30 to n=132 for immune support and fatigue reduction, but evidence quality is rated moderate due to heterogeneous preparations and short durations. No clinical trials to date have specifically evaluated the combined 'Blueberry Reishi' formulation as a single intervention, making efficacy claims for the blend speculative.

Nutritional Profile

This ingredient represents a combination of blueberry (Vaccinium corymbosum/angustifolium) and Reishi mushroom (Ganoderma lucidum) constituents. BLUEBERRY COMPONENT: Anthocyanins (primary bioactives) at approximately 163-487mg/100g fresh weight, predominantly cyanidin-3-glucoside, delphinidin-3-glucoside, malvidin-3-glucoside, and petunidin derivatives; Pterostilbene (~0.5-1.5mcg/g); Resveratrol (trace, <1mcg/g); Vitamin C (~9-14mg/100g fresh equivalent, reduced in powder form due to processing); Vitamin K1 (~19mcg/100g); Manganese (~0.34mg/100g); Dietary fiber (~2.4g/100g fresh equivalent, concentrated in powder); Quercetin glycosides (~7-15mg/100g); Chlorogenic acids (~85-130mg/100g). Bioavailability note: Anthocyanin bioavailability is relatively low (1-2% absorption), enhanced by food matrix and gut microbiota conversion to metabolites like protocatechuic acid. REISHI COMPONENT: Beta-glucans (primary bioactives) at approximately 10-50% dry weight depending on extraction method; Triterpenes/Ganoderic acids (A, B, C, D, G, H) at ~1-3% dry weight in fruiting body; Polysaccharides (heteropolysaccharides, ~10-65% by extraction); Ergosterol (provitamin D2 precursor) ~0.3-0.8mg/g dry weight; Adenosine ~0.1-0.2mg/g; Protein ~7-8% dry weight with all essential amino acids; Minerals: potassium (~2000-3000mg/100g dry), phosphorus (~400mg/100g dry), zinc (~5-6mg/100g dry), iron (~3-4mg/100g dry); Germanium (organic, ~800-2000ppm in some preparations). Bioavailability note: Polysaccharide and triterpene bioavailability is significantly influenced by extraction method — hot water extraction favors beta-glucans while ethanol extraction favors triterpenes; dual extraction maximizes bioactive yield. Combined powder dosages typically range 500-2000mg per serving, with exact concentrations variable by manufacturer.

Preparation & Dosage

No clinical studies exist for a combined Blueberry Reishi product. Separately: Blueberry powder was studied at 50g daily of freeze-dried powder for 8 weeks. Reishi dosages vary by product form with no standardized clinical recommendation provided in available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - no evidence for this product combination

Safety & Interactions

Blueberry at food-equivalent doses is generally recognized as safe (GRAS), but high-dose blueberry extracts may potentiate antiplatelet effects of warfarin, aspirin, and clopidogrel by inhibiting platelet aggregation via COX-1 suppression. Ganoderma lucidum has been associated with dry mouth, dizziness, and gastrointestinal upset in approximately 10–15% of users in clinical studies, and rare cases of hepatotoxicity have been reported with concentrated powdered extracts. Reishi may enhance the effects of antihypertensive and anticoagulant medications, warranting caution in patients on blood thinners or blood pressure drugs. Safety data in pregnancy and lactation is insufficient for both high-dose blueberry extract and Ganoderma supplementation; avoidance during pregnancy is advisable.